Clover Health Investments ROE 2020-2025 | CLOV
Current and historical return on equity (ROE) values for Clover Health Investments (CLOV) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Clover Health Investments ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-09-30 | $-0.06B | $0.34B | -17.03% |
| 2025-06-30 | $-0.04B | $0.34B | -12.62% |
| 2025-03-31 | $-0.03B | $0.34B | -7.44% |
| 2024-12-31 | $-0.04B | $0.34B | -13.23% |
| 2024-09-30 | $-0.09B | $0.34B | -29.24% |
| 2024-06-30 | $-0.12B | $0.33B | -40.16% |
| 2024-03-31 | $-0.16B | $0.29B | -51.67% |
| 2023-12-31 | $-0.21B | $0.29B | -67.51% |
| 2023-09-30 | $-0.23B | $0.32B | -68.12% |
| 2023-06-30 | $-0.26B | $0.33B | -74.41% |
| 2023-03-31 | $-0.34B | $0.32B | -89.66% |
| 2022-12-31 | $-0.34B | $0.36B | -81.15% |
| 2022-09-30 | $-0.44B | $0.39B | -95.45% |
| 2022-06-30 | $-0.40B | $0.43B | -85.87% |
| 2022-03-31 | $-0.62B | $0.49B | -140.09% |
| 2021-12-31 | $-0.59B | $0.54B | -126.79% |
| 2021-09-30 | $-0.53B | $0.41B | -299.86% |
| 2021-06-30 | $-0.48B | $0.32B | -647.30% |
| 2021-03-31 | $-0.16B | $0.59B | 4457.14% |
| 2020-12-31 | $-0.14B | $-0.61B | 90.22% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.214B | $1.371B |
| Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.404B | 55.40 |
| Tempus AI (TEM) | United States | $11.811B | 0.00 |
| Doximity (DOCS) | United States | $8.862B | 36.49 |
| Hims & Hers Health (HIMS) | United States | $8.100B | 65.89 |
| IRhythm Technologies (IRTC) | United States | $5.397B | 0.00 |
| Hinge Health (HNGE) | United States | $3.215B | 0.00 |
| Privia Health (PRVA) | United States | $2.856B | 178.62 |
| Inspire Medical Systems (INSP) | United States | $2.466B | 40.80 |
| Heartflow (HTFL) | United States | $2.248B | 0.00 |
| 10x Genomics (TXG) | United States | $1.987B | 0.00 |
| Enovis (ENOV) | United States | $1.618B | 8.50 |
| Omnicell (OMCL) | United States | $1.534B | 31.37 |
| Azenta (AZTA) | United States | $1.346B | 58.74 |
| Schrodinger (SDGR) | United States | $1.286B | 0.00 |
| Phreesia (PHR) | United States | $1.234B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.891B | 0.00 |
| Claritev (CTEV) | United States | $0.630B | 0.00 |
| Talkspace (TALK) | United States | $0.527B | 106.00 |
| Veradigm (MDRX) | United States | $0.517B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.498B | 0.00 |
| Standard BioTools (LAB) | United States | $0.465B | 0.00 |
| Evolent Health (EVH) | United States | $0.432B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.348B | 0.00 |
| TruBridge (TBRG) | United States | $0.308B | 14.15 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.274B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.256B | 0.00 |
| CapsoVision (CV) | United States | $0.248B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.208B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.192B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.162B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.158B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.152B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.103B | 0.00 |
| Outset Medical (OM) | United States | $0.089B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.073B | 0.00 |
| American Well (AMWL) | United States | $0.065B | 0.00 |
| Pulmonx (LUNG) | United States | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.043B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.043B | 0.00 |
| Precipio (PRPO) | United States | $0.037B | 0.00 |
| 111 (YI) | China | $0.034B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.024B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.021B | 0.00 |
| Zhongchao (ZCMD) | China | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.014B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |